MALAT1 and Alzheimer disease: Moreover, Li et al. demonstrated that MALAT1 may exert its neuroprotective effects against AD pathology by acting as a molecular sponge for miR-30b, thereby leading to upregulated expression of its target CNR1 (cannabinoid receptor 1) (Table S1).